Asia Bio Partnering Forum is your gateway to Asia's emerging innovation. Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia.
The 2026 CPCIC China Pharmaceutical Commercialization Innovation Conference, themed "Driven by Digital Intelligence, Innovated Through Collaboration, Coexisting for Shared Value", will be held in Shanghai on September 22–23, 2026. Centered on three core sectors—digital pharmaceutical marketing, pharmaceutical logistics and supply chain, as well as innovative payment and health insurance—the conference is expected to gather over 800 leaders and practitioners engaged in pharmaceutical commercialization to discuss parallel transformation and in-depth integration across the three fields.
BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering sessions.
As the world's longest-running biotech exhibition, BioJapan, along with its two co-located events —Regenerative Medicine Japan, which accelerates R&D and commercialization in regenerative medicine, and healthTECH Japan, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences— continues to drive innovation and collaboration in the industry.
From cross-border deals to newcos, faster clinical data is fueling the China innovation story, turning biopharmas from Shanghai to Beijing into global players. Multinational pharma and Western VCs have been the first to capitalize, sourcing innovation from China at record levels.
But testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.
This November, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 13th China Healthcare Summit. Get a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.
But testing faster in humans is also a recipe for Western and Asia biotechs to de-risk their own compounds, working with China partners.
This November, BioCentury, BayHelix and Insights Partner McKinsey & Company invite you to visit Shanghai for the 13th China Healthcare Summit. Get a firsthand look at China's biotech ecosystem and build your network with the right biopharmas, investors and CDMOs.
oin us for the 32nd BIO-Europe in Cologne, Germany, November 9–11, 2026—the premier biopharma partnering event, now expanded into a comprehensive forum for the entire biotech ecosystem.
BIO-Europe 2026 convenes the biotech pharma C-suite with seven parallel content tracks covering partnering, investment, therapeutic areas, regulatory developments, clinical affairs, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends, while new access options support different levels of engagement.
A new Content-Only registration is now available for non-partnering attendees, providing access to the exhibit hall, all program tracks, and the Monday evening event. All-Access attendees enjoy the full partnering experience. Join us to strengthen leadership, champion innovation, and foster the global partnerships that drive our industry forward.
BIO-Europe 2026 convenes the biotech pharma C-suite with seven parallel content tracks covering partnering, investment, therapeutic areas, regulatory developments, clinical affairs, and manufacturing strategy. Daily plenary sessions address macro-level industry and policy trends, while new access options support different levels of engagement.
A new Content-Only registration is now available for non-partnering attendees, providing access to the exhibit hall, all program tracks, and the Monday evening event. All-Access attendees enjoy the full partnering experience. Join us to strengthen leadership, champion innovation, and foster the global partnerships that drive our industry forward.
Biotech Showcase, the leading investor conference, returns for its 19th edition January 11-13, 2027, during JPM Week in San Francisco. The event connects over 3,200 global biopharma leaders, including 1,200+ investors and 350+ biotech innovators, facilitating 6,000+ one-on-one meetings through the partneringONE platform. Attendees gain direct access to investors managing $400+ billion in capital, strategic partners, and opportunities to showcase groundbreaking innovations in two specialized showcases—TechBio Showcase and Seed Showcase—within the main conference. Co-produced by Demy-Colton and EBD Group, Biotech Showcase is synonymous with excellence in business support services for the biotechnology industry.
BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group's sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.
ChinaBio® Partnering Forum grants the global biopharma community the opportunity to broaden their reach into the China life science market through unmatched cross-border partnerships.Engage with the largest network of potential partners to accelerate your cross-border strategies and expand your reach into the China market.
Asia Bio Partnering Forum is your gateway to Asia's emerging innovation. Asia Bio Partnering Forum will continue to build on its strong start and will gather biotech and pharma leaders from around the world with hundreds of emerging innovators across Asia Pacific to advance dealmaking in Asia.
BIO-Europe, Europe's premier biopharma partnering event, will connect over 5,500 life science professionals from 2,800+ companies across 60+ countries, facilitating approximately 29,000 one-to-one meetings. The event features comprehensive programming including startup initiatives, industry insights from thought leaders, and the Austrian networking pavilion LISA showcasing the country's thriving biotech ecosystem.
Media Partners






















































